SANA : Interim Report Q1 2024 - MarketScreener
INTERIM REPORT FOR SANIONA AB 556962-5345 January - March 2024 Published May 29, 2024 Advancing our epilepsy assets and driving innovation...
Source: marketscreener.com
Positive Allosteric Modulator News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Positive Allosteric Modulator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Positive Allosteric Modulator Today - Breaking & Trending Today
Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
/PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for...
Source: prnewswire.com
2023-09-14 | NDAQ:BNOX | Press Release
(2023-09-14 | NDAQ:BNOX) Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD
Source: stockhouse.com
Bionomics reports Full Year Financial Results
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
EISAI TO PRESENT THE LATEST LECANEMAB DATA, INCLUDING ARIA-E AND SUBCUTANEOUS FORMULATION, AND OTHER ALZHEIMER'S DISEASE RESEARCH AT THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) 2022
/PRNewswire/ -- Eisai Co. Ltd (Headquarters: Toyoko, CEO: Haruo Naito, "Eisai") announced today that the company will present research from its Alzheimer's...
Source: prnewswire.com